This labelling standard describes the requirements necessary to receive marketing authorization (Drug identification number (DIN)) for oral expectorant nonprescription product containing guaifenesin as a single ingredient for use in adults and children 12 years of age and older to relieve symptoms of common cold.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Guidance document - Nonprescription oral adult expectorant cough and cold labelling standardHTMLEnglish publication HTML
-
Guidance document - Nonprescription oral adult expectorant cough and cold labelling standardHTMLFrench publication HTML
Similar records